204 related articles for article (PubMed ID: 15788679)
1. Legumain expression in relation to clinicopathologic and biological variables in colorectal cancer.
Murthy RV; Arbman G; Gao J; Roodman GD; Sun XF
Clin Cancer Res; 2005 Mar; 11(6):2293-9. PubMed ID: 15788679
[TBL] [Abstract][Full Text] [Related]
2. Expression of MAC30 protein is related to survival and biological variables in primary and metastatic colorectal cancers.
Moparthi SB; Arbman G; Wallin A; Kayed H; Kleeff J; Zentgraf H; Sun XF
Int J Oncol; 2007 Jan; 30(1):91-5. PubMed ID: 17143516
[TBL] [Abstract][Full Text] [Related]
3. Topoisomerase I protein expression in primary colorectal cancer and lymph node metastases.
Boonsong A; Curran S; McKay JA; Cassidy J; Murray GI; McLeod HL
Hum Pathol; 2002 Nov; 33(11):1114-9. PubMed ID: 12454816
[TBL] [Abstract][Full Text] [Related]
4. Expression of FXYD3 protein in relation to biological and clinicopathological variables in colorectal cancers.
Widegren E; Onnesjö S; Arbman G; Kayed H; Zentgraf H; Kleeff J; Zhang H; Sun XF
Chemotherapy; 2009; 55(6):407-13. PubMed ID: 19955746
[TBL] [Abstract][Full Text] [Related]
5. Leptin expression correlates with favorable clinicopathologic phenotype and better prognosis in colorectal adenocarcinoma.
Paik SS; Jang SM; Jang KS; Lee KH; Choi D; Jang SJ
Ann Surg Oncol; 2009 Feb; 16(2):297-303. PubMed ID: 19050975
[TBL] [Abstract][Full Text] [Related]
6. Reduced expression of Apaf-1 in colorectal adenocarcinoma correlates with tumor progression and aggressive phenotype.
Paik SS; Jang KS; Song YS; Jang SH; Min KW; Han HX; Na W; Lee KH; Choi D; Jang SJ
Ann Surg Oncol; 2007 Dec; 14(12):3453-9. PubMed ID: 17882496
[TBL] [Abstract][Full Text] [Related]
7. Metastatic potential in T1 and T2 colorectal cancer.
Fang WL; Chang SC; Lin JK; Wang HS; Yang SH; Jiang JK; Chen WC; Lin TC
Hepatogastroenterology; 2005; 52(66):1688-91. PubMed ID: 16334758
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic features and survival of patients with colorectal mucinous, signet-ring cell or non-mucinous adenocarcinoma: experience at an institution in southern China.
Song W; Wu SJ; He YL; Cai SR; Zhang CH; Zhang XH; Zhan WH
Chin Med J (Engl); 2009 Jul; 122(13):1486-91. PubMed ID: 19719934
[TBL] [Abstract][Full Text] [Related]
9. Expression of heat shock protein 70 (HSP70) in patients with colorectal adenocarcinoma--immunohistochemistry and Western blot analysis.
Milićević ZT; Petković MZ; Drndarević NC; Pavlović MD; Todorović VN
Neoplasma; 2007; 54(1):37-45. PubMed ID: 17233550
[TBL] [Abstract][Full Text] [Related]
10. Reduced p16 expression correlates with lymphatic invasion in colorectal cancers.
Tada T; Watanabe T; Kazama S; Kanazawa T; Hata K; Komuro Y; Nagawa H
Hepatogastroenterology; 2003; 50(54):1756-60. PubMed ID: 14696398
[TBL] [Abstract][Full Text] [Related]
11. High epidermal growth factor receptor expression in metastatic colorectal cancer lymph nodes may be more prognostic of poor survival than in primary tumor.
Deng Y; Kurland BF; Wang J; Bi J; Li W; Rao S; Lan P; Lin T; Lin E
Am J Clin Oncol; 2009 Jun; 32(3):245-52. PubMed ID: 19451802
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of alpha-methylacyl-coenzyme A racemase in colorectal carcinoma bears clinical and pathologic significance.
Lin A; Weiser MR; Klimstra DS; Paty PB; Tang LH; Al-Ahmadie H; Hoo Park S; Guillem JG; Temple L; Wong WD; Gerald WL; Shia J
Hum Pathol; 2007 Jun; 38(6):850-6. PubMed ID: 17442371
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients.
Ottaiano A; Franco R; Aiello Talamanca A; Liguori G; Tatangelo F; Delrio P; Nasti G; Barletta E; Facchini G; Daniele B; Di Blasi A; Napolitano M; Ieranò C; Calemma R; Leonardi E; Albino V; De Angelis V; Falanga M; Boccia V; Capuozzo M; Parisi V; Botti G; Castello G; Vincenzo Iaffaioli R; Scala S
Clin Cancer Res; 2006 May; 12(9):2795-803. PubMed ID: 16675573
[TBL] [Abstract][Full Text] [Related]
14. Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma.
Yamanashi T; Nakanishi Y; Fujii G; Akishima-Fukasawa Y; Moriya Y; Kanai Y; Watanabe M; Hirohashi S
Oncology; 2009; 77(1):53-62. PubMed ID: 19556810
[TBL] [Abstract][Full Text] [Related]
15. Expression of phospholipase D2 in human colorectal carcinoma.
Saito M; Iwadate M; Higashimoto M; Ono K; Takebayashi Y; Takenoshita S
Oncol Rep; 2007 Nov; 18(5):1329-34. PubMed ID: 17914593
[TBL] [Abstract][Full Text] [Related]
16. [The prognostic role of anatomo-pathological factors in colorectal cancer: an univariate analysis].
Coco C; Magistrelli P; Vecchio FM; Roncolini G; Granone P; D'Ugo D; Picciocchi A
Ann Ital Chir; 1991; 62(4):355-62. PubMed ID: 1662923
[TBL] [Abstract][Full Text] [Related]
17. Legumain: a biomarker for diagnosis and prognosis of human ovarian cancer.
Wang L; Chen S; Zhang M; Li N; Chen Y; Su W; Liu Y; Lu D; Li S; Yang Y; Li Z; Stupack D; Qu P; Hu H; Xiang R
J Cell Biochem; 2012 Aug; 113(8):2679-86. PubMed ID: 22441772
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of cyclooxygenase-2 correlates with advanced stages of colorectal cancer.
Zhang H; Sun XF
Am J Gastroenterol; 2002 Apr; 97(4):1037-41. PubMed ID: 12003384
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of Smac/DIABLO expression in colorectal cancer.
Endo K; Kohnoe S; Watanabe A; Tashiro H; Sakata H; Morita M; Kakeji Y; Maehara Y
Oncol Rep; 2009 Feb; 21(2):351-5. PubMed ID: 19148507
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of BMP7 in human colorectal cancer.
Motoyama K; Tanaka F; Kosaka Y; Mimori K; Uetake H; Inoue H; Sugihara K; Mori M
Ann Surg Oncol; 2008 May; 15(5):1530-7. PubMed ID: 18259822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]